Close Menu
  • Home
  • Tech&AI
    • Claude AI
    • Chatgpt
    • Gemini
    • Grok
  • News
    • Canada
    • United States
    • Australia
    • Europe
    • Asia
    • Africa
    • Politics
  • Classifieds Toronto
  • Service Canada
    • Immigration and citizenship
    • Renew your passport online in Canada
    • Service Canada
    • Service Ontario
      • Service Toronto
    • Service Alberta
      • Service Edmonton
      • Service Calgary
    • British Columbia
      • Victoria
      • Vancouver
    • Manitoba
      • Winnipeg
    • Quebec
      • Quebec City
      • Montreal
    • Newfoundland and Labrador
      • St. John’s
    • New Brunswick
      • Fredericton
      • Saint John
    • Nova Scotia
      • Halifax
    • Prince Edward Island
      • Charlottetown
    • Saskatchewan
      • Regina
      • Saskatoon
  • Education&Jobs
    • Universities in Canada
    • Toronto public schools
    • Free English lessons
    • Language Assessment and Referral Services
    • Toronto Public Library
    • Jobs in Canada
    • Job-Manpower
  • Home&Lifestyle
    • Buy or Rent a house
      • Realtor
      • Apartments for Rent in Toronto
    • Health
      • General hospital locations
      • Find a doctor or nurse
      • Health Canada
      • Toronto Health & Wellness
      • LifeLabs-Canada’s largest lab
    • Travel
      • Travel and tourism
      • Visit Toronto
      • Air Canada
    • Entertainment
    • Sports
  • Business
    • Finance
      • TD Bank
      • RBC Bank
      • CIBC Bank
      • BMO Bank
      • Scotia Bank
      • National Bank
    • Investing
      • Invest Canada
    • Companies
      • Ontario Business Registry
      • Trademarks
    • Stocks
      • Toronto stock Exchange
      • The New York Stock Exchange
      • Nasdaq: Stock Market
      • Yahoo Finances
    • Markets
      • Exhibition place
      • Metro Toronto Convention Centre
      • THE INTERNATIONAL CENTRE
      • Traders Forum Show
    • Crypto
    • Economy
  • Store
    • Make grocery shopping simple
    • Shopping Centres & Department Stores
    • COSTCO
    • Canadian Tire
    • Home Depot
    • Walmart
    • Foodbanks & Charities
  • Free TV
    • Free TV
    • Watch Free Movies Online with Plex
    • Korean TV
  • Free Games
    • Free Game1
    • Free game2
    • Europe
What's Hot

US basketball player arrested in Nigeria over 75 pounds of cannabis

November 17, 2026

Bodies of mother, young son pulled from Craigieburn lake in Melbourne’s north

November 17, 2026

Madison Huang, Jensen Huang’s Daughter, Became a Powerful Force at Nvidia

November 17, 2026
Facebook X (Twitter) Instagram
Tuesday, November 17
The Smart Times Toronto
Subscribe
  • Home
  • Tech&AI
    • Claude AI
    • Chatgpt
    • Gemini
    • Grok
  • News
    1. Canada
    2. United States
    3. Australia
    4. Europe
    5. Asia
    6. Africa
    7. Politics
    8. View All

    Nova Scotia officials warn toxic drugs increasingly mixed with veterinary sedative – Halifax

    November 17, 2026

    Proposed Saint John data centre could generate tax windfall, critics unconvinced – New Brunswick

    November 17, 2026

    Carney meets with President Xi in Shenzhen, China ahead of APEC summit – National

    November 16, 2026

    Flying out of Kelowna is about to get more expensive as airport fees increase – Okanagan

    November 16, 2026

    US basketball player arrested in Nigeria over 75 pounds of cannabis

    November 17, 2026

    Victim Advocates Sue Newsom Over Attempt to Empty California’s Death Row

    November 17, 2026

    DHS says ICE detainer ignored as illegal immigrant freed from Rikers Island

    November 17, 2026

    El Niño Draws Sea Turtles to California’s Coast for the First Time

    November 17, 2026

    Bodies of mother, young son pulled from Craigieburn lake in Melbourne’s north

    November 17, 2026

    Dramatic videos show bullet paths from killer cop's gun

    November 17, 2026

    Simon Thuijs: Concerns for welfare of WA man, originally from Geraldton, missing in Brisbane since weekend

    November 17, 2026

    India skipper Gill faces 'good headache' before NZ Test

    November 17, 2026

    Trump to kick off Asia trip with Quad talks in Manila ahead of China visit

    November 17, 2026

    Odds rise of Trump-Kim meeting on APEC sidelines, analysts say

    November 17, 2026

    Malaysia and France upgrade ties, strengthen cooperation in defence and rare earths

    November 17, 2026

    Head of China’s Baidu warns of AI ‘bubble’ ahead of APEC talks

    November 17, 2026

    White House “tiger team” formed to prevent another nationwide ground stop

    November 17, 2026

    The Blue Wave Lifted Democrats. But Not All Progressives Rose as High.

    November 17, 2026

    Chargers, Justin Herbert finally win first game of season after brutal mistake by Ravens star

    November 17, 2026

    Protests flare in Philippines over Trump’s visit and planned AI hub

    November 17, 2026

    US basketball player arrested in Nigeria over 75 pounds of cannabis

    November 17, 2026

    Bodies of mother, young son pulled from Craigieburn lake in Melbourne’s north

    November 17, 2026

    Trump to kick off Asia trip with Quad talks in Manila ahead of China visit

    November 17, 2026

    Irish ‌‌‌‌boxer Lee Reeves, 31, dies three months after sustaining injuries | Boxing

    November 17, 2026
  • Classifieds Toronto
  • Service Canada
    • Immigration and citizenship
    • Renew your passport online in Canada
    • Service Canada
    • Service Ontario
      • Service Toronto
    • Service Alberta
      • Service Edmonton
      • Service Calgary
    • British Columbia
      • Victoria
      • Vancouver
    • Manitoba
      • Winnipeg
    • Quebec
      • Quebec City
      • Montreal
    • Newfoundland and Labrador
      • St. John’s
    • New Brunswick
      • Fredericton
      • Saint John
    • Nova Scotia
      • Halifax
    • Prince Edward Island
      • Charlottetown
    • Saskatchewan
      • Regina
      • Saskatoon
  • Education&Jobs
    • Universities in Canada
    • Toronto public schools
    • Free English lessons
    • Language Assessment and Referral Services
    • Toronto Public Library
    • Jobs in Canada
    • Job-Manpower
  • Home&Lifestyle
    • Buy or Rent a house
      • Realtor
      • Apartments for Rent in Toronto
    • Health
      • General hospital locations
      • Find a doctor or nurse
      • Health Canada
      • Toronto Health & Wellness
      • LifeLabs-Canada’s largest lab
    • Travel
      • Travel and tourism
      • Visit Toronto
      • Air Canada
    • Entertainment
    • Sports
  • Business
    • Finance
      • TD Bank
      • RBC Bank
      • CIBC Bank
      • BMO Bank
      • Scotia Bank
      • National Bank
    • Investing
      • Invest Canada
    • Companies
      • Ontario Business Registry
      • Trademarks
    • Stocks
      • Toronto stock Exchange
      • The New York Stock Exchange
      • Nasdaq: Stock Market
      • Yahoo Finances
    • Markets
      • Exhibition place
      • Metro Toronto Convention Centre
      • THE INTERNATIONAL CENTRE
      • Traders Forum Show
    • Crypto
    • Economy
  • Store
    • Make grocery shopping simple
    • Shopping Centres & Department Stores
    • COSTCO
    • Canadian Tire
    • Home Depot
    • Walmart
    • Foodbanks & Charities
  • Free TV
    • Free TV
    • Watch Free Movies Online with Plex
    • Korean TV
  • Free Games
    • Free Game1
    • Free game2
    • Europe
The Smart Times Toronto
Home»Health
Health

An Intriguing Approach to Slow Alzheimer’s Shows Mixed Results

Press RoomBy Press RoomNovember 16, 2026No Comments8 Mins Read
Facebook Twitter Pinterest LinkedIn Reddit Telegram WhatsApp
Share
Facebook Twitter LinkedIn Pinterest Reddit Telegram WhatsApp

The largest trial to date of a headset device that delivers flickering light and sound in an attempt to slow the progression of Alzheimer’s has delivered mixed results.

The device is based on the theory that audiovisual stimulation can evoke brainwave responses that might help preserve neurological function and clear waste from the brain. The idea is appealing because, if such a treatment works, it could provide an accessible non-drug alternative to Alzheimer’s medications that are expensive and carry significant safety risks.

Results of the study of the device, presented on Monday evening at a major Alzheimer’s conference, showed that the 12-month trial involving participants with mild to moderate Alzheimer’s did not achieve its primary goal. The overall group of patients who used the audiovisual device did not experience slower cognitive decline than those who used an inactive placebo device called a sham.

Patients with moderate Alzheimer’s showed no benefit at all from the system, called Spectris, according to data provided by the company, Cognito Therapeutics, which sponsored the trial. But for patients with mild Alzheimer’s, data generally suggested they could experience slower decline with the device, particularly if they used it nearly every day for close to the recommended 60 minutes.

Based on that, Cognito’s chief executive, Christian Howell, said the company planned to seek Food and Drug Administration approval.

“The signal we found in the mild population is really incredible,” Mr. Howell said in an interview. He attributed the trial’s failure to meet its primary goal to “the lack of treatment effect” in patients with moderate Alzheimer’s, but said that for mildly impaired patients, “there is a very clear path for us to the F.D.A.”

Some Alzheimer’s experts disagreed with that interpretation. They said more research was needed because they did not consider the results convincing enough to suggest a successful treatment for mildly impaired patients.

“Unfortunately, this is a negative trial and can only suggest that a new trial be performed in the mild Alzheimer’s group,” said Dr. Lon Schneider, who directs the California Alzheimer’s Disease Center at the University of Southern California.

In the trial, about half of the 663 participants were randomly assigned to receive the active device, designed to stimulate gamma waves in the brain to a frequency of 40 cycles per second (or 40 Hz). The other participants received a sham device.

Results for the overall population of participants, presented at the Clinical Trials on Alzheimer’s Disease conference in Boston, showed that after 12 months, those who received the active device declined by an average of 8.97 points on the 108-point primary scale used in the study, which combined measures of cognition and ability to perform daily activities. Participants who received the inactive device declined by an average of 8.82 points — showing no significant difference between the active and inactive treatment. The results have not yet been peer-reviewed or published in a journal.

Among patients considered moderately impaired, those who used the active device declined an average of 4.38 points, or 36 percent more than those who used the sham device.

Among mildly impaired patients, results trended in the opposite direction, with those using the active device declining an average of three points, or 42 percent slower than those who received the sham device.

The overall results for both moderate and mild groups did not meet the statistically significant threshold that scientists consider necessary for reliable findings.

Fewer than half the participants used their devices enough to be following the trial’s optimal protocol: at least 50 minutes per hourlong session, at least five days a week, for at least six months of the yearlong study.

But mildly impaired patients who followed that protocol did show statistically significant benefit from the active device, the study reported. Those 88 patients declined an average of five points, or 73 percent slower than the 81 patients who used the sham device according to the protocol.

Dr. Scott Small, director of the Alzheimer’s Disease Research Center at Columbia University, said the results of the overall trial were “disappointing,” especially since “the promise that a non-pharmacological intervention, one that can be potentially widely available, was met with high enthusiasm.”

Some experts said the countervailing results for mild and moderate patients made it harder to identify a clear pattern of benefit. Dr. Schneider said it was surprising “that one subgroup would benefit and the other would worsen, almost as mirror images of each other.”

He added: “Perhaps this could be useful in more mildly impaired people. However, another study has to be done to show that.”

Laura Nisenbaum, executive director of the Alzheimer’s Drug Discovery Foundation, a funder of Cognito, said the foundation had been “very intrigued by the mechanism because this is taking a very different approach.”

But she said she needed to see more data “to truly understand how robust, if any, signal they have.”

Dr. Nisenbaum said that, “if this were a drug, this essentially would not support submission for approval” because, for medication trials, if the primary goal is not met, “you do not advance to go.”

Cognito officials said they expected the F.D.A. to apply a different standard to a device like Spectris.

“For the first time, a medical device is coming into the world of Alzheimer’s, and that means that the F.D.A. process is just very different,” Mr. Howell said.

For example, said Dr. Robbert Zusterzeel, the company’s chief clinical and regulatory officer, while drug trials of this size would be considered small, the study is large for device trials. He said he believed the F.D.A. would welcome the fact that Spectris could be used at home without serious safety risks.

The theory behind the device is that gamma waves in the brain relate to cognitive processes like attention and memory. In Alzheimer’s, neuronal communication is disrupted, and gamma activity is often reduced.

Research in animals led by two Massachusetts Institute of Technology scientists, Li-Huei Tsai and Edward Boyden, who also co-founded Cognito, has found beneficial effects from using flickering light and sound to evoke gamma oscillations at a frequency of 40 Hz.

“You can think of it like a carwash, so it can clear a lot of the metabolic waste in the brain,” Dr. Tsai, director of the M.I.T. Picower Institute for Learning and Memory, said, adding that it also “increases synaptic plasticity and has this direct protective effect on neurons.”

“In the early days, we got a lot of criticism” from other scientists, she said. “People would be saying ‘Oh, this is like a fairy tale. You just use this very simple, straightforward light and sound stimulation, and it’s just too easy.’”

She said criticism lessened as she and others conducted more research. She said she was not directly involved in the Cognito trial, but believed it showed that mild Alzheimer’s patients could benefit and that regular device users “get the best treatment effect.”

Dr. Small said one important unanswered question was whether participants showed favorable changes in their levels of Alzheimer’s-related proteins — an indicator of whether or not the device could slow the disease process. Cognito said it expected to analyze that and other data in the coming months.

Cognito connected The New York Times to a trial participant with mild Alzheimer’s who received the active intervention.

The patient, Mireya Miranda, 78, of Miami, said she wore the headset daily, even taking it on a trip to Turkey. She said the sound through the headphones resembled staticky rain and what she saw in the glasses resembled a snowy television screen.

Her husband, Alberto, said his wife was very dedicated, but “it was an inconvenience.” Asked if the device seemed to slow her decline, he said, “I didn’t notice any difference.”

Ms. Miranda said she was now participating in another Alzheimer’s trial, involving infusions of an experimental drug. Asked if she would use the headset again if it became available, she replied, “If I have to do it again, I won’t.” She added, “I will not use it again because that hour seemed like three hours.”

In an interview also arranged by Cognito, Ms. Miranda’s neurologist, Dr. Andrew Lerman, an investigator in the trial, said Ms. Miranda was “very motivated” and consistently used the device. He said that gauging whether it helped her was challenging because Alzheimer’s trajectories vary widely, but that his staff believed she would have declined more without it.

He said some of his patients quit the trial. Some found the device “agitating to wear” or “just didn’t like having something on their face,” he said. But some patients enjoyed the experience, he said, and some are ineligible for Alzheimer’s drugs or like “the idea of a therapy where they don’t need to take another pill.”

Share. Facebook Twitter Pinterest LinkedIn Reddit Telegram WhatsApp
Press Room
  • Website

Keep Reading

Measles Is Sickening More Pregnant Women and Newborns, Alarming Doctors

John H. Powers III to Lead NIAID Amid Turmoil

This Cancer Kills Children in a Year. Research Has Been Stalled for a Year.

Finally, a Vaccine for Cancer

American Global Health Aid Isn’t Dead. It’s Changing.

Research Stalls for a Year Into a Cancer That Kills Children in a Year

Add A Comment
Leave A Reply Cancel Reply

THJ MAILBOX SERVICES
GOLDBAY TELECOM INC.
Facebook X (Twitter) Pinterest Vimeo WhatsApp TikTok Instagram

News

  • World News
  • United States
  • Canada
  • Europe
  • Australia
  • Asia
  • Africa

Business

  • Stocks
  • Economy
  • Finance
  • Investing
  • Markets
  • Companies
  • Crypto

SITE LINKS

  • Newsletter
  • Community
  • Work with us
  • Press Room
  • Media
  • Cookie Policy
  • About Us

Subscribe to Updates

Get the latest politics, business, sports, lifestyle, and many more news directly to your inbox.

© 2026 The Smart Times Toronto. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Press Release
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.